Buy & Sell Gilead Sciences, Inc. (GILD) – Gilead Sciences, Inc. Price Today
Key Stats
- $153.66BMarket Cap
- HealthSector
- -14.5%3M Drawdown
- $168.19BEnterprise Value
- 2.65%Dividend Yield
- 97 daysTypical Hold Time
Gilead Sciences, Inc. (GILD) is currently valued at a market capitalization of $153.66B, with an enterprise value of $168.19B. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $105.93 and a high of $155.8, highlighting its annual price range. Over the past three months, Gilead Sciences, Inc. has recorded a drawdown of -14.5%, reflecting recent price volatility. Gilead Sciences, Inc. offers a dividend yield of 2.65%, with the most recent dividend of $0.82 paid on 15 Jun 26. On average, investors hold Gilead Sciences, Inc. for approximately 97 days, indicating typical investor behavior on the platform.
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Most Recent News
Invesco QQQ Trust offers broad AI-driven tech exposure with strong 2026 growth and easy single-ticker access.
The Invesco QQQ Trust provides investors a single ticker to access the top 100 largest non-financial Nasdaq companies, heavily weighted in AI and tech leaders like NVIDIA, Microsoft, and Apple. It has delivered strong returns, up over 20% year-to-dat...
Senators demand FCC pause Paramount-Warner Bros merger over foreign ownership concerns.
Three Democratic senators have called on the FCC to halt the $110 billion Paramount-Warner Bros Discovery merger due to concerns about nearly 50% foreign ownership, including investments from Saudi Arabia and Gulf states. They urge a thorough nationa...
Paramount-Skydance $111B Warner Bros. merger risks 2,500 LA jobs amid $82B debt and local film decline
Paramount Skydance's $111 billion acquisition of Warner Bros. Discovery threatens about 2,500 jobs in Los Angeles County and 6,000 globally due to overlapping roles and cost-cutting aimed at managing an $82 billion debt. The merger may reduce local f...